VCAM1 and Hepatic fibrosis: Taken together, the findings in the current study suggest that VCAM1 in LSECs is not just a scaffold for leukocyte adhesion, but also a direct modulator of liver fibrosis, further strengthening the potential efficacy of targeting VCAM1 in chronic liver disease patients in clinical settings.